{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05416125",
            "orgStudyIdInfo": {
                "id": "PEDS-2022-30981"
            },
            "organization": {
                "fullName": "University of Minnesota",
                "class": "OTHER"
            },
            "briefTitle": "Vyvanse in Children Aged 6 to 12 Years",
            "officialTitle": "Lisdexamfetamine for the Treatment of Severe Obesity in Children Aged 6 to 12 Years",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "vyvanse-in-children-aged-to-years"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-11-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-11-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-08",
            "studyFirstSubmitQcDate": "2022-06-08",
            "studyFirstPostDateStruct": {
                "date": "2022-06-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-20",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Minnesota",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will randomize children who have difficulty maintaining a healthy weight to one of two treatment groups: lifestyle therapy plus lisdexamfetamine or lifestyle therapy plus placebo.",
            "detailedDescription": "This pilot study will enroll up to 40 children aged 6 to 12 years who have severe obesity. Individuals will be randomized to receive lifestyle therapy plus lisdexamfetamine or lifestyle therapy plus placebo. Participants will receive therapy for 24 weeks."
        },
        "conditionsModule": {
            "conditions": [
                "Obesity, Childhood"
            ],
            "keywords": [
                "Obesity"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Lifestyle therapy plus placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Individuals randomized to this arm will receive lifestyle therapy plus placebo for 24 weeks.",
                    "interventionNames": [
                        "Behavioral: Lifestyle therapy"
                    ]
                },
                {
                    "label": "Lifestyle therapy plus lisdexamfetamine",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Individuals randomized to this arm will receive lifestyle therapy plus lisdexamfetamine for 24 weeks.",
                    "interventionNames": [
                        "Drug: Lisdexamfetamine Dimesylate"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Lisdexamfetamine Dimesylate",
                    "description": "Vyvanse treatment",
                    "armGroupLabels": [
                        "Lifestyle therapy plus lisdexamfetamine"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Lifestyle therapy",
                    "description": "Lifestyle treatment",
                    "armGroupLabels": [
                        "Lifestyle therapy plus placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percent change in Body Mass Index",
                    "description": "The primary outcome is the percent change in body mass index (BMI) from randomization to Week 24",
                    "timeFrame": "24 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Children ages 6 to \\<12 years at study entry\n* Severe obesity defined as BMI \\>/= 1.2 times the 95th percentile\n* Prior failed attempt of lifestyle therapy per parent/guardian report\n* Written informed consent of parent/legal guardian and written assent of participant\n\nExclusion Criteria:\n\n* Contraindications to lisdexamfetamine, including current or recent (\\< 14 days) use of monoamine oxidase inhibitor and known hypersensitivity to amphetamine products\n* Family history of sudden death or ventricular arrhythmia\n* Clinically significant congenital or structural heart disease or arrhythmia\n* Hypertension defined as systolic blood pressure (SBP) and/or diastolic blood pressure (DBP) \\>/= 95th percentile\n* Tachycardia defined heart rate (HR) \\>/= 120 bpm\n* Current or recent (\\< 3 months) use of psychostimulant or sympathomimetic amine\n* History of chemical dependency\n* Positive urine drug screen\n* Diabetes mellitus (type 1 or 2)\n* Current or recent (\\< 3 months) use of anti-obesity medication(s)\n* Previous bariatric surgery\n* Recent initiation or change in dose (\\< 3 months prior) of anti-hypertensive or lipid medication(s)\n* Thyroid stimulating hormone (TSH) \\> 1.5x upper limit of normal (ULN)\n* Aspartate transaminase (AST) or alanine transaminase (ALT) \\> 3x ULN\n* Fasting glucose \\>/= 126 mg/dL\n* History of mania, schizophrenia, bipolar disorder, or psychosis\n* Unstable depression or anxiety that has required hospitalization in the past 12 months\n* Any history of suicide attempt\n* Columbia Suicide Severity Rating Scale (C-SSRS) of type 4 or 5 in past month\n* Children's Depressive Inventory 2 (CDE-2_ score \\>/= 70\n* Concomitant use of tricyclic antidepressants, selective serotonin re-uptake inhibitors (SSRIs), serotonin and norepinephrine re-uptake inhibitors (SNRIs), lithium, fentanyl, tramadol, triptans, tryptophan, buspirone and St. John's wort\n* Refusal to use adequate contraception (double barrier method or stable hormonal contraception plus single barrier method, tubal ligation, or abstinence) in girls of childbearing potential",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "6 Years",
            "maximumAge": "12 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Claudia Fox, MD",
                    "role": "CONTACT",
                    "phone": "(612) 626-6616",
                    "email": "lusc0001@umn.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Claudia Fox, MD",
                    "affiliation": "University of Minnesota",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Minnesota",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55414",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Claudia Fox, MD",
                            "role": "CONTACT",
                            "phone": "612-626-6616",
                            "email": "lusc0001@umn.edu"
                        },
                        {
                            "name": "Lisa Hostetler, BA",
                            "role": "CONTACT",
                            "phone": "(612) 624-0149",
                            "email": "hoste005@umn.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009765",
                    "term": "Obesity"
                },
                {
                    "id": "D000063766",
                    "term": "Pediatric Obesity"
                }
            ],
            "ancestors": [
                {
                    "id": "D000050177",
                    "term": "Overweight"
                },
                {
                    "id": "D000044343",
                    "term": "Overnutrition"
                },
                {
                    "id": "D000009748",
                    "term": "Nutrition Disorders"
                },
                {
                    "id": "D000001835",
                    "term": "Body Weight"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "asFound": "Obesity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30155",
                    "name": "Pediatric Obesity",
                    "asFound": "Obesity, Childhood",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12702",
                    "name": "Obesity, Morbid",
                    "relevance": "LOW"
                },
                {
                    "id": "M26186",
                    "name": "Overweight",
                    "relevance": "LOW"
                },
                {
                    "id": "M25307",
                    "name": "Overnutrition",
                    "relevance": "LOW"
                },
                {
                    "id": "M12684",
                    "name": "Nutrition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5114",
                    "name": "Body Weight",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000069478",
                    "term": "Lisdexamfetamine Dimesylate"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000697",
                    "term": "Central Nervous System Stimulants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018765",
                    "term": "Dopamine Uptake Inhibitors"
                },
                {
                    "id": "D000014179",
                    "term": "Neurotransmitter Uptake Inhibitors"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000015259",
                    "term": "Dopamine Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M446",
                    "name": "Lisdexamfetamine Dimesylate",
                    "asFound": "Distal Radius",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4029",
                    "name": "Central Nervous System Stimulants",
                    "relevance": "LOW"
                },
                {
                    "id": "M7473",
                    "name": "Dopamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M20832",
                    "name": "Dopamine Uptake Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M17962",
                    "name": "Dopamine Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "CaAg",
                    "name": "Cardiotonic Agents"
                }
            ]
        }
    },
    "hasResults": false
}